These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 335687)

  • 21. [Pindolol in arterial hypertension. A double-blind study (author's transl)].
    Basso B; Roman O
    Rev Med Chil; 1976 Mar; 104(3):143-7. PubMed ID: 781772
    [No Abstract]   [Full Text] [Related]  

  • 22. [The efficiency of coronary therapy with Visken (pindolol). A combined clinical and experimental analysis (author's transl)].
    Delius L; Lübke KO
    Med Klin; 1974 Jun; 69(25):1117-23. PubMed ID: 4602393
    [No Abstract]   [Full Text] [Related]  

  • 23. [Minoxidil in treatment resistant hypertension].
    Tenschert W; Vetter W; Studer A; Reuteler H; Furrer J; Nussberger J; Siegenthaler W
    Schweiz Med Wochenschr; 1979 Dec; 109(47):1869-73. PubMed ID: 531565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pindolol in hypertension: a double-blind trial.
    Feltham PM; Watson OF; Peel JS; Dunlop DJ; Turner AS
    N Z Med J; 1972 Sep; 76(484):167-71. PubMed ID: 4564997
    [No Abstract]   [Full Text] [Related]  

  • 25. Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial.
    Pathak L; Hiremath ; Kerkar PG; Manade VG
    J Assoc Physicians India; 2004 Mar; 52():197-202. PubMed ID: 15636308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A field study with the combination of Pindolol and Clopamid in antihpertensive therapy (author's transl)].
    Rosenthal J; Meurer KA; Escobar-Jimenez F; Zoupas C; Lang R; Laaser U; Kuschinsky G; Raptis S; Welzel D
    Med Klin; 1978 Oct; 73(42):1481-6. PubMed ID: 30034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double-blind factorial trial of prindolol and hydrochlorothiazide in hypertension.
    Chalmers JP; Korner PI; Tiller DJ; Bune AJ; Steiner JD; West MJ; Wing LM; Uther JF
    Med J Aust; 1976 May; 1(18):650-3. PubMed ID: 781495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of pindolol on serum lipids, apolipoproteins, and lipoproteins in patients with mild to moderate essential hypertension.
    Sasaki J; Saku K; Ideishi M; Arakawa K; Kato Y; Kuwano E; So T
    Clin Ther; 1989; 11(2):219-24. PubMed ID: 2736568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double blind study of Visken LB-46, in the treatment of angina pectoris.
    Nair DV
    Indian Heart J; 1972 Jun; 24():Suppl 1:183-91. PubMed ID: 4581426
    [No Abstract]   [Full Text] [Related]  

  • 30. Multicenter evaluation of mepindolol and of mepindolol plus hydrochlorothiazide in essential hypertension.
    Masoni A; Galassi A; Ginevrino P; Libretti A; Morgagni W; Rappelli A; Tomasi AM
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):546-50. PubMed ID: 6757152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The treatment of angina pectoris with a fixed combination of a beta-adrenoceptor blocker and a long-acting nitrate (double-blind trial) (author's transl)].
    Greif S; Roth F; Harnoncourt K
    Schweiz Rundsch Med Prax; 1977 Nov; 66(48):1554-9. PubMed ID: 337281
    [No Abstract]   [Full Text] [Related]  

  • 32. Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension.
    Svetkey LP; Weinberger MH; Gavras H; Gavras I; Brown TS; Deterding J; Klotman PE
    J Clin Hypertens; 1987 Dec; 3(4):579-88. PubMed ID: 3330988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Labetalol compared with prindolol plus hydraliazine in the treatment of hypertension: a double-blind cross-over study.
    Barnett AJ; Kalowski S; Guest C
    Med J Aust; 1978 Jan; 1(2):105-9. PubMed ID: 349319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the therapeutic effect of transdermal beta-blocker therapy in patients with essential hypertension.
    Spieker C; Vetter W; Zidek W; Vetter H
    Arzneimittelforschung; 1989 Nov; 39(11A):1512-4. PubMed ID: 2576202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The influence of a long-term cardioselective and noncardioselective beta-receptorblockade on blood pressure, O2-uptake and carbohydrate metabolism. Ergometric investigations in hypertensive patients (author's transl)].
    Franz IW; Lohmann FW
    Z Kardiol; 1979 Jul; 68(7):503-9. PubMed ID: 473853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Duration of action of a fixed beta blocker-diuretic combination. Randomized double-blind study].
    Niederhauser HU
    Schweiz Rundsch Med Prax; 1982 Jun; 71(22):949-54. PubMed ID: 7050962
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of hypertension with a combination of pyridopyridazine derivative with a beta-receptor blocker. Studies on the hemodynamic course (author's transl)].
    Lehmann HU; Witt E; Hochrein H
    MMW Munch Med Wochenschr; 1978 Jun; 120(23):803-6. PubMed ID: 26870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The long-term effect of isradipine in pindolol-treated patients.
    Dahlöf B; Andrén L; Eggertsen R; Jern S; Svensson A; Hansson L
    J Hypertens Suppl; 1987 Dec; 5(5):S567-70. PubMed ID: 2965231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Controlled study of high blood pressure treatment using betablocker Visken (author's transl)].
    Ripka O; Linhartová J; Jarolím M; Okrouhlík B; Chvatíková J
    Sb Lek; 1975 Oct; 77(10):294-7. PubMed ID: 1101360
    [No Abstract]   [Full Text] [Related]  

  • 40. [Beta receptor block versus calcium antagonism. A comparative study of bopindolol and nifedipine with special regard to quality of life].
    Welzel D; Bräutigam M
    Arzneimittelforschung; 1989 Apr; 39(4):499-503. PubMed ID: 2568838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.